Correlation Between Regenxbio and Anebulo Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Regenxbio and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Anebulo Pharmaceuticals.

Diversification Opportunities for Regenxbio and Anebulo Pharmaceuticals

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Regenxbio and Anebulo is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Regenxbio i.e., Regenxbio and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Regenxbio and Anebulo Pharmaceuticals

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Anebulo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.37 times less risky than Anebulo Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Anebulo Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  209.00  in Anebulo Pharmaceuticals on October 24, 2024 and sell it today you would lose (50.00) from holding Anebulo Pharmaceuticals or give up 23.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Regenxbio  vs.  Anebulo Pharmaceuticals

 Performance 
       Timeline  
Regenxbio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Regenxbio and Anebulo Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regenxbio and Anebulo Pharmaceuticals

The main advantage of trading using opposite Regenxbio and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.
The idea behind Regenxbio and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets